Lava Therapeutics (Netherlands)

Lava Therapeutics is a company in Utrecht, Netherlands, focused on developing its Gammabody® platform to transform cancer therapy. The Gammabody® platform generates bispecific gamma delta T cell engagers that specifically activate a unique and relatively abundant effector gamma-delta T cell subset called Vγ9Vδ2 T cells. This approach is designed to complement natural tumor recognition, direct Vγ9Vδ2 T cells to the tumor, selectively kill cancer cells and trigger an immune response cascade. The company states that to date it is the only company developing bispecific gamma delta T cell engaging antibodies for the treatment of cancer. Its board of directors includes chair Kapil Dhingra, M.B.B.S., and director Jay Backstrom, M.D., M.P.H.

Lava Therapeutics is a company in Utrecht, Netherlands. It focuses on developing its Gammabody® platform to transform cancer therapy. The Gammabody® platform generates bispecific gamma delta T cell engagers that specifically activate a unique and relatively abundant effector gamma-delta T cell subset called Vγ9Vδ2 T cells. This approach is designed to complement natural tumor recognition, direct Vγ9Vδ2 T cells to the tumor, selectively kill cancer cells and trigger an immune response cascade. The company states that to date it is the only company developing bispecific gamma delta T cell engaging antibodies for the treatment of cancer. In 2025, Lava Therapeutics was the subject of a tender offer by XOMA Royalty, and the company announced exceeding the minimum condition in the tender offer and its intent to delist from Nasdaq.

To date, we are the only company developing bispecific gamma delta T cell engaging antibodies for the treatment of cancer.

• Gammabody® platform

  Generates bispecific gamma delta T cell engagers that specifically activate Vγ9Vδ2 T cells.

• 2021-04-01

  LAVA Therapeutics appoints Karen J. Wilson to its board[4]LAVA Therapeutics任命Karen J. Wilson为董事会成员medindia.net

  LAVA Therapeutics announced that Karen J. Wilson was appointed to its Board of Directors and as chair of its Audit Committee.

1. 1Lava Therapeuticslavatherapeutics.com
2. 2Company Overview - Lava Therapeuticslavatherapeutics.com
3. 3Board of Directors - Lava Therapeuticslavatherapeutics.com
4. 4LAVA Therapeutics任命Karen J. Wilson为董事会成员medindia.net